2023-08-03 16:46:39 ET
- Artivion press release ( NYSE: AORT ): Q2 Non-GAAP EPS of $0.06 beats by $0.04 .
- Revenue of $89.3M (+11.2% Y/Y) beats by $5.06M .
- Achieved EBITDA of $9.2 million in the second quarter of 2023; non-GAAP adjusted EBITDA increased 35% to $13.8 million in the second quarter of 2023 compared to the second quarter of 2022
- Aortic stent graft revenues increased 19% on both a GAAP and non-GAAP constant currency basis in the second quarter of 2023 compared to the second quarter of 2022
- On-X revenues increased 10% on a GAAP basis and 11% on a non-GAAP constant currency basis in the second quarter of 2023 compared to the second quarter of 2022
For further details see:
Artivion Non-GAAP EPS of $0.06 beats by $0.04, revenue of $89.3M beats by $5.06M